.INVESTIGATION HIGHLIGHT.06 August 2024.
A large randomized measured trial with cisgender girls highlights the problems of faithfulness to a daily dental preexposure treatment program and also illustrates that twice-yearly injection of lenacapavir may maintain successful HIV deterrence amounts over 6 months.